Dignitana AB Publishes Q1 2024 Interim Report
Continued progress with increasing activity and awareness Financial highlights Q1 2024 · Net Sales amounted to 21.2 MSEK (21.5), a decrease of 2 percent over the same quarter in 2023. · Operating Result amounted to -5.0 MSEK (-3.5). · Net Result after financial items amounted to -5.1 MSEK (-3.9). · EBITDA for the First Quarter is negative at -1.1 MSEK (0.2). · Earnings per share were -0.07 SEK (-0.06). · Cash Balance amounted at 2.8 MSEK (11.7). · Average Daily Treatment Revenue (ADTR)* was 241 TSEK (242) in the quarter. Business highlights during the period